Vagistat-1


Indications and Reactions:

Role Indications Reactions
Primary
Vulvovaginal Mycotic Infection 85.6%
Genital Pruritus Female 4.5%
Fungal Infection 3.5%
Vaginal Burning Sensation 2.5%
Vaginal Discharge 1.5%
Blood Cholesterol Increased 1.0%
Contraception 0.7%
Hormone Replacement Therapy 0.7%
Drug Ineffective 24.5%
Vaginal Swelling 19.4%
Vaginal Burning Sensation 15.2%
Vulvovaginal Discomfort 9.3%
Vaginal Discharge 5.6%
Genital Pruritus Female 4.8%
Vaginal Haemorrhage 4.5%
Wrong Technique In Drug Usage Process 3.5%
Drug Administration Error 2.4%
Pruritus 1.6%
Vaginal Erythema 1.6%
Vulvovaginal Mycotic Infection 1.1%
Vulvovaginal Pruritus 1.1%
Dysuria 0.8%
Fungal Infection 0.8%
Localised Oedema 0.8%
Nausea 0.8%
Oedema Genital 0.8%
Ovarian Disorder 0.8%
Skin Irritation 0.8%
Secondary
Genital Pruritus Female 50.0%
Vaginal Burning Sensation 37.5%
Vaginal Discharge 12.5%
Drug Ineffective 50.0%
Nausea 25.0%
Vaginal Burning Sensation 25.0%

Drug Data